TBI-304

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameTBI-304
Drug Alias NameHRC-304TBI-304HTBI-304
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionStem cells stimulantsErythropoiesis stimulantsScavenger receptor cysteine-rich type 1 protein M130 stimulants
TargetsScavenger receptor cysteine-rich type 1 protein M130
Therapy Area/IndicationsAnemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesHemosol Biopharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHemosol Biopharma
Active IndicationsN/A
Inactive IndicationsAnemia

Other Information

ATC CodeN/A
Related LinksN/A